Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-13 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,688 | $22.11 | $678,660 | 872,620 (Indirect Direct) | View |
| 2024-07-01 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $22.14 | $68,204 | 119,256 (Direct) | View |
| 2024-06-06 Sale | 2024-06-10 8:06 pm | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 1,458 | $21.73 | $31,682 | 20,038 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 4:28 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,674 | $20.39 | $34,133 | 116,369 (Direct) | View |
| 2024-04-15 Sale | 2024-04-17 5:14 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.29 | $30,471 | 118,043 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:07 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-19 4:27 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $20.1 | $33,487 | 119,709 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 5:38 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.37 | $30,604 | 121,375 (Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:16 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:15 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 9,589 | $17.29 | $165,794 | 2,480,671 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,189 | $17.46 | $73,130 | 351,824 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 22,844 | $17.62 | $402,420 | 711,090 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:26 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.42 | $30,688 | 123,041 (Direct) | View |
| 2024-01-10 Sale | 2024-01-12 8:18 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,668 | $19.02 | $88,785 | 356,013 (Indirect Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:28 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 7,818 | $19.78 | $154,640 | 2,490,260 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:35 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 9,972 | $19.43 | $193,756 | 360,681 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:34 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 3,208 | $19.43 | $62,331 | 992,591 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:34 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 9,972 | $19.43 | $193,756 | 683,934 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:33 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 17,483 | $19.43 | $339,695 | 2,498,078 (Indirect Direct) | View |
| 2023-12-15 Sale | 2023-12-18 7:30 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $23.39 | $38,968 | 124,707 (Direct) | View |
| 2023-11-15 Sale | 2023-11-16 6:14 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $19.13 | $31,871 | 126,373 (Direct) | View |
| 2023-10-16 Sale | 2023-10-18 4:44 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $20.66 | $34,420 | 128,039 (Direct) | View |
| 2023-09-15 Sale | 2023-09-19 4:45 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $23.62 | $39,348 | 129,705 (Direct) | View |
| 2023-08-23 Sale | 2023-08-25 5:36 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,522 | $23.17 | $58,435 | 640,186 (Indirect Direct) | View |
| 2023-08-23 Sale | 2023-08-25 5:30 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,522 | $23.22 | $58,561 | 316,933 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:34 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,478 | $22.6 | $56,003 | 319,455 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-31 Option Award | 2024-06-04 6:33 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 23,868 | $0 | 921,209 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:32 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 23,868 | $0 | 36,581 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:31 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 23,868 | $0 | 2,135,309 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:30 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 23,868 | $0 | 140,237 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:30 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 23,868 | $0 | 39,397 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:29 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 23,868 | $0 | 96,861 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:28 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 23,868 | $0 | 364,397 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:27 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Harris Erik Director | 23,868 | $0 | 34,953 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:20 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 23,868 | $0 | 39,397 (Direct) | View |
| 2024-03-29 Gift | 2024-03-29 5:59 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0 | 2,440,671 (Indirect) | View |
| 2024-02-08 Exercise | 2024-02-12 4:48 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 50,000 | $0.68 | 879,012 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 4:48 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 50,000 | $0 | 879,012 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:57 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 214,880 | $0 | 855,066 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:57 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 214,880 | $0 | 531,813 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 5:56 pm | N/A 2034-01-02 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 358,080 | $0 | 2,784,121 (Direct) | View |